Use of desferrioxamine in the treatment of aceruloplasminemia

Annals of Neurology

Volumn 41, Issue 3, 1997, Pages 404-407

  Miyajima, Hiroaki ^a   Takahashi, Yoshitomo ^a   Kamata, Tadashi ^a   Shimizu, Hideaki ^a   Sakai, Naoki ^a   Gitlin, Jonathan D ^b,c  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE MESYLATE;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; DEGENERATIVE DISEASE; ELECTROMYOGRAM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON METABOLISM; LABORATORY TEST; LIPID PEROXIDATION; METABOLIC DISORDER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CERULOPLASMIN; DEFEROXAMINE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IRON; IRON METABOLISM DISORDERS; LIVER; MIDDLE AGED; SIDEROPHORES;

EID: 0031058837     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410318     Document Type: Article

References (15)

1. Takahashi N, Ortel TL, Putnam FW. Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule. Proc Natl Acad Sci USA 1984;81:390-394
2. Miyajima H, Nishimura Y, Mizoguchi K, et al. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987;37:761-767
3. Logan JI, Harveyson KB, Wisdom GB, et al. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q J Med 1994;87:663-670
4. Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995;37:646-656
5. Harris ZL, Takahashi Y, Miyajima H, et al. Aceruloplasminemia: molecular characterization of a novel disorder or iron metabolism. Proc Natl Acad Sci USA 1995;92:2539-2542
6. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995;9:267-272
7. Daimon M, Kato T, Kawanami T, et al. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem Biophys Res Commun 1995;89:217-221
8. Takahashi Y, Miyajima H, Shirabe S, et al. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet 1996;5: 81-84
9. Harris ZL, Migas MC, Hughes AE, et al. Familial dementia due to a frameshift mutation in the caeruloplasmin gene. Q J Med 1996;89:355-359
10. Connor JR, Benkovic A. Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann Neurol 1992;32:S51-S61
11. Elston JS. A new variant of blepharospasm. J Neurol Neurosurg Psychiatry 1992;55:369-371
12. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new calorimetric method. Clin Chim Acta 1978; 90:37-43
13. Summers MR, Jacobs A, Tudway D, et al. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol 1979;42:547-555
14. Miyajima H, Takahashi Y, Serizawa M, et al. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic Biol Med 1996;20:757-760
15. Klomp LWJ, Farhangrazi ZS, Dugan LL, Gitlin JD. Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 1996;98:207-215